The effect of BCG on in vitro immune reactivity and clinical course in dogs treated surgically for osteosarcoma.
D000818:Animals; D000912:Antibodies, Neoplasm / Q000032:analysis; D001500:BCG Vaccine; D001667:Binding, Competitive; D004285:Dogs; D005260:Female; D007111:Immunity, Cellular; D007958:Leukocyte Count; D008214:Lymphocytes; D008297:Male; D009163:Mycobacterium bovis / Q000276:immunology*; D009362:Neoplasm Metastasis; D012516:Osteosarcoma / Q000276:immunology / Q000601:surgery / Q000628:therapy*; D012513:Sarcoma, Experimental / Q000628:therapy; D013997:Time Factors
D000912:Antibodies, Neoplasm; D001500:BCG Vaccine